Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response, company says

In a Phase 1/2 clinical trial, Moderna’s combination vaccine appeared to elicit “strong” immune responses against both influenza and Covid-19 and was found to be safe, the company announced Wednesday.